Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02631746
Title Nivolumab in Treating Patients With HTLV-Associated T-Cell Leukemia/Lymphoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

adult T-cell leukemia/lymphoma

Therapies

Nivolumab

Age Groups: adult
Covered Countries USA


No variant requirements are available.